Aurinia Pharmaceuticals Inc.
NASDAQ: AUPH0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Kevin C. Tang
- Employees
- 130
- Headquarters
- Edmonton, Canada
- IPO year
- 2014
- Market cap
- $2.4B
- Website
- https://www.auriniapharma.com
Loading AUPH…
Loading profile data…Frequently asked questions about AUPH
What does Aurinia Pharmaceuticals Inc. (AUPH) do?
Aurinia Pharmaceuticals Inc. operates as a commercial-stage biopharmaceutical company, specializing in the development and commercialization of innovative therapies. Its core mission is to address a variety of diseases for which current medical solutions are inadequate, serving patient populations across the United States and internationally. Th...
Where does AUPH trade?
Aurinia Pharmaceuticals Inc. (AUPH) trades on the NASDAQ Global Market.
What sector is AUPH in?
Aurinia Pharmaceuticals Inc. (AUPH) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Aurinia Pharmaceuticals Inc.?
Kevin C. Tang is the chief executive officer of Aurinia Pharmaceuticals Inc. (AUPH).
Where is Aurinia Pharmaceuticals Inc. headquartered?
Aurinia Pharmaceuticals Inc. is headquartered in Canada.
Does AUPH pay a dividend?
Aurinia Pharmaceuticals Inc. (AUPH) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AUPH go public?
Aurinia Pharmaceuticals Inc. (AUPH) completed its initial public offering in 2014.